Cynthia Butitta
Director/Board Member presso UROGEN PHARMA LTD.
Patrimonio netto: 1 M $ in data 31/03/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Cyrus Harmon | M | 54 | 18 anni | |
| Martin Pulé | M | 51 |
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | 10 anni |
| Christian Martin Itin | M | 59 |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | 10 anni |
| Martin Murphy | M | 55 |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | 10 anni |
| John Berriman | M | 76 |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | 10 anni |
| Ian Clark | M | 62 | 5 anni | |
| Peter Kushner | M | 86 | 18 anni | |
| Gregory Russotti | M | 57 | 4 anni | |
| Elizabeth Barrett | F | 62 | 5 anni | |
| Joseph Jimenez | M | 64 | 5 anni | |
| Christine Cassiano | F | - | 8 anni | |
| Kapil Dhingra | M | 64 |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | 10 anni |
| Douglas Carr | M | - | 6 anni | |
| Linda Bain | F | 53 |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | 6 anni |
| Sean Bohen | M | 58 | 4 anni | |
| Joseph Anderson | M | 65 |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | 8 anni |
| Shane Kovacs | M | 50 | 4 anni | |
| Dong Kim | M | 47 | 3 anni | |
| Carlo Rizzuto | M | 53 | 6 anni | |
| Olivia Manser | F | - | 2 anni | |
| David Brochu | M | - | 5 anni | |
| Kimberly Blackwell | M | 55 | 3 anni | |
| Alex Driggs | M | 48 | - | |
| Brent Pfeiffenberger | M | - | 1 anni | |
| Gorjan Hrustanovic | M | 35 | 6 anni | |
| Jason Smith | M | 52 | 4 anni | |
| Sandra Horning | M | 75 | 4 anni | |
| Alexander Swan | M | - | 3 anni | |
| Kenneth J. Dow | M | - | - | |
| Alessandro Riva | M | 63 | 3 anni | |
| Timothy Walbert | M | 57 | 2 anni | |
| J. Garland | M | 55 | 1 anni | |
| Andy Rappaport | M | 66 | 11 anni | |
| Fred Cohen | M | 67 | 7 anni | |
| Stuart Holden | M | 82 | 9 anni | |
| Hyam Levitsky | M | 66 | 5 anni | |
| Yi Larson | F | 44 | 3 anni | |
| Daphne Quimi | F | 58 | 2 anni | |
| Graham Walmsley | M | 37 | 4 anni | |
| Julie Dexter | F | - | - | |
| Leana Wen | M | 41 | 2 anni | |
| Brent Rice | M | 58 | 3 anni | |
| Kristin Lanzi | F | - | - | |
| Kamesh Kuchimanchi | M | - | 2 anni | |
| Bryon Wornson | M | - | 2 anni | |
| Sasha Austin | F | - | 3 anni | |
| Naseem Zojwalla | M | 51 | 2 anni | |
| James Robinson | M | 54 | 1 anni | |
| Marina Konorty | M | - | 13 anni | |
| Mark Schoenberg | M | 66 | 8 anni | |
| William Young | M | 79 | 3 anni | |
| Henry C. Montgomery | M | 88 |
Catalyst Semiconductor, Inc.
 Catalyst Semiconductor, Inc. SemiconductorsElectronic Technology Catalyst Semiconductor, Inc. engages in the design, development and sale of semiconductor products. Its products are used in communication, computing, industrial automation, consumer and automotive applications. It offers serial and parallel Flash/electrically erasable programmable read only memories (EEPROM), programmable micro-controller supervisory and voltage reference circuits and mixed signal devices. The company was founded in 1985 and is headquartered in Santa Clara, CA. | 24 anni |
| Sorin Georgescu | M | 72 |
Catalyst Semiconductor, Inc.
Catalyst Semiconductor, Inc. SemiconductorsElectronic Technology Catalyst Semiconductor, Inc. engages in the design, development and sale of semiconductor products. Its products are used in communication, computing, industrial automation, consumer and automotive applications. It offers serial and parallel Flash/electrically erasable programmable read only memories (EEPROM), programmable micro-controller supervisory and voltage reference circuits and mixed signal devices. The company was founded in 1985 and is headquartered in Santa Clara, CA. | 23 anni |
| George Smarandoiu | M | 77 |
Catalyst Semiconductor, Inc.
Catalyst Semiconductor, Inc. SemiconductorsElectronic Technology Catalyst Semiconductor, Inc. engages in the design, development and sale of semiconductor products. Its products are used in communication, computing, industrial automation, consumer and automotive applications. It offers serial and parallel Flash/electrically erasable programmable read only memories (EEPROM), programmable micro-controller supervisory and voltage reference circuits and mixed signal devices. The company was founded in 1985 and is headquartered in Santa Clara, CA. | 22 anni |
| David Myles | M | 62 | 16 anni | |
| James Ottinger | M | - | 7 anni | |
| Shane N. O. Williams | M | - | - | |
| Vincent I. Perrone | M | - | 2 anni | |
| Robert Dolski | M | 54 | 1 anni | |
| Arie Belldegrun | M | 74 | 12 anni | |
| Moran Mieron | M | 52 | - | |
| Robert Iannone | M | 57 | 1 anni | |
| Robert Azelby | M | 56 | - | |
| Christopher Vann | M | 59 | 8 anni | |
| Veronica Hersberger | M | - | 1 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Jay Shepard | M | 66 |
Telik, Inc.
 Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA.
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | 7 anni |
| Lucinda Crabtree | M | 45 | 3 anni | |
| Wendy Wee | F | 71 |
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA.
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | 17 anni |
| Shawn Tomasello | F | 65 | 7 anni | |
| Gil Hakim | M | 54 | 8 anni | |
| Osvaldo Flores | M | - | - | |
| Gail L. Brown | M | 73 |
Altair Capital Associates LLC
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | 3 anni |
| Aya Jakobovits | M | 71 | 3 anni | |
| David Tanen | M | 52 | - | |
| Peter Pfreundschuh | M | 55 | 2 anni | |
| John Johnson | M | 66 | 3 anni | |
| Elizabeth Faust | M | 59 | 2 anni | |
| Paul L. Jenkinson | M | 64 | 1 anni | |
| Edward W. Cantrall | M | 92 |
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | 12 anni |
| David Chang | M | 64 | 4 anni | |
| Jeffrey Wiezorek | M | 52 | - | |
| Steven R. Goldring | M | 80 |
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | 12 anni |
| Ronald Bentsur | M | 58 | 4 anni | |
| Wendy K. Wee | F | 71 |
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | - |
| John Moriarty | M | 56 | 3 anni | |
| Francis McCormick | M | 73 | 7 anni | |
| Greg Mann | M | - | - | |
| Ran Nussbaum | M | 51 | 10 anni | |
| John Higgins | M | 54 |
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | 9 anni |
| Jay Backstrom | M | 69 | 3 anni | |
| Herwig von Morzé | M | 85 |
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | 8 anni |
| Elyse G. Seltzer | M | 59 | 6 anni | |
| Timothy Moore | M | 62 | 3 anni | |
| Richard B. Newman | M | 85 |
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | 11 anni |
| Claudine Prowse | M | - | - | |
| Matthias Alder | M | 59 | 4 anni | |
| Edward Hodgkin | M | 61 |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | 4 anni |
| Franz Humer | M | 76 | 2 anni | |
| Stefan Ryser | M | 64 |
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | 11 anni |
| Stephen Mullennix | M | - | 2 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 77 | 77.00% |
| Regno Unito | 23 | 23.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Cynthia Butitta
- Contatti personali
